Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

IXJ vs. GGHCX: which is better?

Bottom line

IXJ vs GGHCX: the short answer

IXJ (iShares Global Healthcare ETF) and GGHCX (INVESCO Health Care Fund) share a meaningful slice of their top holdings — about 51% by weight.

IXJ is cheaper at 0.38% vs 1.07% — a difference of $69 a year per $10,000 invested.

Over five years, IXJ returned +6.4% a year vs +2.6% for GGHCX.

GGHCX has a front-end sales load of up to 5.5%; the other does not.

Updated Nov 19, 2026

IXJ vs GGHCX side by side

IXJGGHCX
TypeETFMutual fund
Fund familyiSharesInvesco
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.38%1.07%
Annual cost per $10k$38$107
10-yr cost on $10k (prospectus)$480$1,784
Max front loadNone5.5%
12b-1 fee0%0.25%
1-yr return+14.9%+9.2%
5-yr return (annualized)+6.4%+2.6%
10-yr return (annualized)+8.2%+5.8%
Best quarter+13.6%+19.6%
Worst quarter−11.8%−16.5%
Net assets (fund)$3.8B$1.2B
Number of holdings12482
Portfolio turnover2%59%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearIXJGGHCXDifference
2025+14.9%+15.5%−0.6%
2024+0.6%+4.0%−3.4%
2023+3.5%+3.1%+0.4%
2022−4.7%−13.5%+8.8%
2021+19.5%+12.2%+7.3%
2020+12.5%+14.5%−2.0%
2019+23.4%+32.0%−8.6%
2018+2.9%+0.5%+2.4%
2017+20.3%+15.5%+4.9%
2016−6.2%−11.7%+5.5%

Source: Fund prospectus bar charts

Holdings overlap

9 of IXJ's top 25 holdings also appear in GGHCX's top 25.

Shared top holdings
HoldingIXJGGHCX
Eli Lilly And Company10.93%10.59%
Johnson & Johnson7.04%6.76%
Abbvie Inc.5.12%4.03%
Unitedhealth Group Incorporated4.40%6.17%
Merck & Co., Inc.4.12%4.59%
Thermo Fisher Scientific Incorporated2.42%1.55%
Gilead Sciences, Inc.2.04%3.63%
Cvs Health Corporation1.71%2.52%
Vertex Pharmaceuticals Incorporated1.64%2.01%

Source: SEC Form N-PORT

IXJ top 10

  1. Eli Lilly And Company — 10.93%
  2. Johnson & Johnson — 7.04%
  3. Abbvie Inc. — 5.12%
  4. Unitedhealth Group Incorporated — 4.40%
  5. Merck & Co., Inc. — 4.12%
  6. Astrazeneca Plc — 3.76%
  7. Roche Holding AG — 3.75%
  8. Novartis AG — 3.71%
  9. Amgen Inc. — 2.54%
  10. Thermo Fisher Scientific Incorporated — 2.42%

GGHCX top 10

  1. Eli Lilly and Co. — 10.59%
  2. Johnson & Johnson — 6.76%
  3. UnitedHealth Group Inc. — 6.17%
  4. Invesco Private Prime Fund — 4.67%
  5. Merck & Co., Inc. — 4.59%
  6. AbbVie Inc. — 4.03%
  7. Gilead Sciences, Inc. — 3.63%
  8. argenx SE — 3.24%
  9. CVS Health Corp. — 2.52%
  10. Welltower Inc. — 2.34%

FAQ

What is the difference between IXJ and GGHCX?
IXJ (iShares Global Healthcare ETF) and GGHCX (INVESCO Health Care Fund) share a meaningful slice of their top holdings — about 51% by weight. IXJ is cheaper at 0.38% vs 1.07% — a difference of $69 a year per $10,000 invested.
Which is cheaper, IXJ or GGHCX?
IXJ has the lower expense ratio (0.38%).
Should I own both IXJ and GGHCX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.